[Protection of Rho-associated protein kinase inhibitor Y-27632 in MRL/lpr mice].
Objective To investigate the immunological effect of Rho-associated protein kinase inhibitor Y-27632 on MRL/lpr mice and explore its underlying mechanisms. Methods The study collected 10 wild-type C57BL/6 mice as normal controls and 20 MRL/lpr mice that were randomly assigned to MRL/lpr group and 5 mg/kg Y-27632-treated MRL/lpr group, with 10 mice in each group. Superoxide dismutase (SOD), methane dicarboxylic aldehyde (MDA), interleukin 6 (IL-6), IL-1β and tumor necrosis factor α (TNF-α) in the serum or spleen were detected by ELISA. The protein levels of thioredoxin-interacting protein/thioredoxin (Txnip/Trx), MAPK-associated protein ERK, JNK, p38 and NF-κB were detected by Western blot analysis. T lymphocytes were isolated and cultured from the groups, and then subjected to Western blotting for evaluating the levels of Txnip/Trx, MAPK, NF-κB proteins and to ELISA for determining the levels of IL-6, IL-1β, TNF-α in the supernatants. Results Compared with the MRL/lpr group, the level of SOD increased and MDA decreased in the serum and spleen; the levels of IL-6, IL-1β, TNF-α were reduced in the serum, spleen and the supernatant of T cells from the spleen; the protein levels of Txnip/Trx, MAPK, NF-κB from the spleen were inhibited and the level of Trx in the spleen was raised in MRL/lpr mice treated with Y-27632. Conclusion Ros kinase inhibitor Y-27632 has protective effects on MRL/lpr lupus mice.